Claisen rearrangement based on TLC analysis of the reac-
tion mixture. For example, ketone formation had begun
within 30 min for 2-Br benzaldehyde, while 2,4-dimethyl-
benzaldehyde required 24 h for the ketone to begin to
appear. Similarly, the electron-poor or -neutral aldehydes
were heated at ca. 60À65 °C for 16 h to effect the re-
arrangement step, while the 2,4-dimethylbenzaldehyde-
derived ketone 11j required 48 h and the 2-oxy substituted
ketones 11f,i required 72 h at ca. 80À85 °C.
There are several practical benefits to this Claisen-based
method for the synthesisofcomplex diaryl 3° alcohols such
as 13aÀj.19,20 First, benzothiazoles are very common
heteroaromatic motifs in medicinal chemistry.21 AC-265347
and analogs thereof, for example, have been reported to be
calcium sensing receptor agonists (Figure 3).22 They were
prepared in the traditional fashion by addition of 2-lithio-
benzothiazole to the corresponding ketones at À78 °C. By
contrast, we prepared allyl analog 13j in 50% yield over
two steps from benzothiazole using our all-organic Claisen
approach.15b
Second, 2-lithiothiazole and -benzothiazole have been em-
ployed extensively in synthesis as acyl anion equivalents.23
These organometal reagents are not compatible with a large
number of comparatively acidic and/or electrophilic func-
tional groups.24 This necessitates the deployment of protec-
tive groups, with the attendant decrease in step economy25
and process efficiency.26 The mildness of the Claisen-based
approach avoids the need for protective groups for hydroxyl
Figure 3. Calcium sensing AC-265347 and allyl analog 13j.
and phenoxy groups and will presumably tolerate many
other comparatively acidic functionalities.
Third, unlike organometal-based approaches that re-
quire ethereal solvents, the above transformations were
carried out in methanol. Methanol is generally considered
to be a green solvent,27 which is an important considera-
tion for process and/or production scale synthesis.
Finally, the conventional approach to 3° alcohol synthe-
sis employing highly reactive organo Li or Mg nucleophiles
generally requires cryogenic conditions. This can be proble-
matic on production scale and requires more expensive
reactor equipment and careful monitoring of reaction tem-
perature due to the danger of exotherms.28 By contrast, only
mild heating is necessary to effect the Metzger condensa-
tion/Claisen rearrangement sequence. Increasing the scale
of the reaction to 10 g of benzothiazolium salt 9 provided a
77% yield of 13a with no alteration of reaction conditions.
In conclusion, we have prepared a variety of benzothia-
zole-based complex 3° alcohols in two steps under mild
conditions without the use of any organometallic reagents.
We continue to investigate the scope of the reaction.
(18) (a) Maki, B. E.; Chan, A.; Scheidt, K. A. Synthesis 2008, 1306–
1315. (b) Abaee has reported that Cannizzaro reactions can occur under
similar conditions catalyzed by LiBr: Mojtahedi, M. M.; Akbarzadeh,
E.; Sharifi, R.; Abaee, M. S. Org. Lett. 2007, 9, 2791–2793. However,
exchange of the bromide counterion of 9a for a tosylate resulted in no
significant change in the reaction outcome, suggesting the Cannizzaro
reaction is NHC catalyzed.
(19) For less conventional anionic approaches to related compounds,
see: Popov, I.; Do, H.-Q.; Daugulis, O. J. Org. Chem. 2009, 74, 8309–
8313. Hirono, Y.; Kobayashi, K.; Yonemoto, M.; Kondo, Y. Chem.
Commun. 2010, 7623–7624.
Acknowledgment. The authors thank the NSF (CHE-
0911638), the NIH (P30RR031154), and the Arkansas Bio-
sciences Institute for support of this work and the Ministry of
Education of Saudi Arabia for a graduate fellowship for S.A.
(20) For other nonmetallic approaches to similar compounds, see:
(a) Burns, N. Z.; Hackman, B. M.; Ng, P. Y.; Powelson, I. A.; Leighton,
J. L. Angew. Chem., Int. Ed. 2006, 45, 3811–3813. (b) Khodakovskiy,
P. V.; Mykhailiuk, P. K.; Volochnyuk, D. M.; Tolmachev, A. A.
Synthesis 2010, 1633–1638.
Supporting Information Available. Experimental pro-
1
cedures, compound characterization data, and H and
13C NMR spectra of 13aÀj. This material is available free
(21) For example, see: (a) Rai, G.; Vyjayanti, V. N.; Dorjsuren, D.;
Simeonov, A.; Jadhav, A.; Wilson, D. M., III; Maloney, D. J. J. Med.
Chem. 2012, 55, 3101–3112. (b) Ochiai, K.; Takita, S.; Eiraku, T.;
Kojima, A.; Iwase, K.; Kishi, T.; Fukuchi, K.; Yasue, T.; Adams,
D. R.; Allcock, R. W.; Jiang, Z.; Kohno, Y. Bioorg. Med. Chem. 2012,
20, 1644–1658. (c) Spadaro, A.; Frotscher, M.; Hartmann, R. W. J. Med.
Chem. 2012, 55, 2469–2473. (d) Li, K.; Frankowski, K. J.; Belon, C. A.;
Neuenswander, B.; Ndjomou, J.; Hanson, A. M.; Shanahan, M. A.;
Schoenen, F. J.; Blagg, B. S. J.; Aube, J.; Frick, D. N. J. Med. Chem.
2012, 55, 3319–3330. (e) Arasappan, A.; Bennett, F.; Girijavallabhan,
V.; Huang, Y.; Huelgas, R.; Alvarez, C.; Chen, L.; Gavalas, S.; Kim,
S.-H.; Kosinski, A.; Pinto, P.; Rizvi, R.; Rossman, R.; Shankar, B.; Tong,
L.; Velazquez, F.; Venkatraman, S.; Verma, V. A.; Kozlowski, J.; Shih,
N.-Y.; Piwinski, J. J.; MacCoss, M.; Kwong, C. D.; Clark, J. L.; Fowler,
A. T.; Geng, F.; Kezar, H. S., III; Roychowdhury, A.; Reynolds, R. C.;
Maddry, J. A.; Ananthan, S.; Secrist, J. A., III; Li, C.; Chase, R.; Curry,
S.; Huang, H.-C.; Tong, X.; Njoroge, F. G. Bioorg. Med. Chem. Lett.
2012, 22, 3229–3234. (f) Sharma, A. K.; Pavlova, S. T.; Kim, J.;
Finkelstein, D.; Hawco, N. J.; Rath, N. P.; Kim, J.; Mirica, L. M.
J. Am. Chem. Soc. 2012, 134, 6625–6636. (g) Ward, R. A.; Brassington, C.;
Breeze, A. L.; Caputo, A.; Critchlow, S.; Davies, G.; Goodwin, L.; Hassall,
G.; Greenwood, R.; Holdgate, G. A.; Mrosek, M.; Norman, R. A.;
Pearson, S.; Tart, J.; Tucker, J. A.; Vogtherr, M.; Whittaker, D.; Wingfield,
J.; Winter, J.; Hudson, K. J. Med. Chem. 2012, 55, 3285–3306.
(22) (a) Gustafsson, M.; Jensen, J.; Bertozzi, S. M.; Currier, E. A.;
Mab, J.-N.; Burstein, E. S.; Olsson, R. Bioorg. Med. Chem. Lett. 2010,
20, 5918–5921. (b) Ma, J.-N.; Owens, M.; Gustafsson, M.; Jensen, J.;
Tabatabaei, A.; Schmelzer, K.; Olsson, R.; Burstein, E. S. J. Pharmacol.
Exp. Therap. 2011, 337, 275–284.
(23) Dondoni, A.; Marra, A. Chem. Rev. 2004, 104, 2557–2599.
(24) There is a single report of a 2-organolanthanide benzothiazole
addition to a ketone: Wunderlich, S. H.; Knochel, P. Chem.;Eur. J.
2010, 16, 3304–3307.
(25) Wender, P. A.; Verma, V. A.; Paxton, T. J.; Pillow, T. H. Acc.
Chem. Res. 2008, 41, 40–49.
(26) Henderson, R. K.; Constable, D. J. C.; Jimeniz-Gonzalez, C. In
Green Chemistry in the Pharmaceutical Industry; Dunn, P. J., Wells, A. S.,
Williams, M. T., Eds.; Wiley-VCH: Weinheim, 2010; pp 21À48.
(27) Constable, D. J. C.; Jimenez-Gonzalez, C.; Henderson, R. K.
Org. Process Res. Dev. 2007, 11, 133–137.
(28) For example, see: Copp, R. R.; Abraham, B. D.; Farnham, J. G.;
Twose, T. M. Org. Process Res. Dev. 2011, 15, 1344–1347.
The authors declare no competing financial interest.
Org. Lett., Vol. 15, No. 1, 2013
5